The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler ... generic competition. All three strengths of the competitor branded as ...
The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler ... to market the generic dubbed Wixela Inhub in three strengths: fluticasone ...
Verywell Health on MSN2mon
Comparing Asthma Inhalers: How to ChooseThis reduces the amount of drug deposited on your cheeks ... or Flexhaler. Wixela Inhub is also a DPI. Soft mist inhalers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback